Latest News
Europe close: Shares get a jolt to extend rally late in session
European shares rallied at the close as a positive start on US markets boosted sentiment late in the session on the back of a softer jobs report that raised hopes of an easing in pricing pressures.
London close: Stocks rise on buoyant global sentiment
London stocks enjoyed a day of robust gains, closing significantly higher on Tuesday following a strong performance from Asian markets.
Director dealings: IQGeo director linked to purchase, BHP CEO covers tax bill
IQGeo Group was on the list of director buys on Tuesday, after it received notification on 26 August from Kestrel Partners that, on 25 August, it purchased on behalf of its discretionary clients an aggregate of 59,950 ordinary shares at an average price of 298p per share.
Europe midday: Shares hold gains on China optimism, Wall St
European shares held gains at midday on Tuesday following positive sessions in the US and Asia.
Wednesday preview: UK mortgage and lending stats in focus
Wednesday is set to be a quiet day for corporate earnings, so the focus will likely be on a barrage of economic data from both home and abroad.
FTSE 250 movers: Housebuilders in focus as UK govt plans to relax pollution rules
In equity markets, housebuilders were on the rise following reports that Housing Secretary Michael Gove was planning a major change to rules on waterway pollution in a bid to build thousands more homes in England.
US job openings decline in July
The number of job openings at US companies declined in July, according to data released on Tuesday.
US consumer confidence unexpectedly tanks in August
US consumer confidence unexpectedly slumped in August as rising prices and concerns about future interest-rate hikes continued to drag on sentiment.
US open: Stocks edge higher as investors await key economic data
Wall Street stocks edged higher on Tuesday, though gains were modest as investors treaded carefully ahead of a barrage of US economic data later in the week.
US house prices rise again in June
US house prices rose again in June, according to the latest S&P/Case-Shiller national home price index.
Star Energy buys majority stake in Croatian project developer
Star Energy announced the acquisition of a 51% stake in A14 Energy on Tuesday, through its subsidiary GT Energy Croatia (GTEC), for total cash consideration of €1. 3m.
Scancell appoints healthcare finance veteran as new CFO
Immunotherapy developer Scancell announced the appointment of Sath Nirmalananthan as its new chief financial officer on Tuesday, effective immediately.
Polarean's Xenoview gets US reimbursement code
Medical device developer Polarean Imaging announced on Tuesday that its Xenoview technology has been granted a new reimbursement code by the US Centers for Medicare and Medicaid Services (CMS).
hVIVO announces new Canary Wharf trial facility
Human challenge trial specialist hVIVO announced plans to open a new state-of-the-art facility at the rapidly-expanding life sciences hub in Canary Wharf, London on Tuesday.
Belvoir buys two financial services firms
Property and financial service franchise Belvoir Group announced the acquisition of two financial services businesses on Tuesday - MAB South West and BMA Bristol - as part of its ongoing growth strategy.
OptiBiotix reports solid progress across product lines
OptiBiotix Health announced a number of commercial advancements in an update on Tuesday, disclosing its highest-ever brand-specific online sales levels in July.
Wilko redundancies paused as administrators consider bids
Job cuts for Wilko’s 12,500 staff were reportedly halted on Tuesday, amid ongoing discussions over the future of the troubled retailer.
FTSE 100 movers: Housebuilders, Bunzl rally
London’s FTSE 100 was up 1. 4% at 7,441. 15 in afternoon trade on Tuesday.
Somero president steps down ahead of interim results
Somero Enterprises announced on Tuesday that John Yuncza had stepped down from his position as president and from its board of directors, effective 28 August.
Hutchmed tumour therapy candidate gets breakthrough designation
Pharmaceuticals developer Hutchmed China announced on Tuesday that the Center for Drug Evaluation of China's National Medical Products Administration (NMPA) has granted breakthrough therapy designation (BTD) to its investigational drug savolitinib.